[Neuroprotective effect of choline succinate in rats with experimental chronic cerebral ischemia evaluated by cognitive ability tests].
The neuroprotective effect of choline succinate was studied in rats with chronic cerebral ischemia induced by ligation of both common carotid arteries. Two approaches were used to evaluate the neuroprotective effect: cognitive ability tests (passive avoidance test and Morris water maze test) and determination of the brain content of N-acetylaspartate, a marker of functional neurons, by 1H NMR spectroscopy in vivo. Choline succinate administration significantly improved memory and learning in ischemic rats and prevented the ischemia-induced decrease in the cerebral level of N-acetylaspartate. Thus, choline succinate demonstrated a neuroprotective effect in conditions of ischemic brain injury.
N A
NA
Pomytkin
Z I
ZI
Storozheva
N A
NA
Semenova
A T
AT
Proshin
V V
VV
Sherstnev
S D
SD
Varfolomeev
D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000032:analysis / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002545:Brain Ischemia / Q000378:metabolism / Q000503:physiopathology*; D002794:Choline / Q000008:administration & dosage*; D002908:Chronic Disease; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D019802:Succinic Acid / Q000008:administration & dosage*
D018696:Neuroprotective Agents; D001224:Aspartic Acid; C000179:N-acetylaspartate; D019802:Succinic Acid; D002794:Choline